Increases Two Sigma Ventures assets under management to $1.8 billion
NEW YORK, Sept. 14, 2022–(BUSINESS WIRE)–Two Sigma Ventures today announced the closing of two venture funds aimed at driving the next era of technological innovation. Totaling $400 million across both funds, Two Sigma Ventures IV (TSV IV) will invest in early-stage startups and Two Sigma Ventures Opportunity Fund II (TSV Opps II) will invest in growth-stage companies. Approximately 85% of the new capital will come from outside investors, primarily institutions such as college endowments, charitable foundations, pension funds and hospital systems, while the remainder of the capital will come from partners and Two Sigma executives.
Two Sigma Ventures invests in many industries including enterprise SaaS, fintech, techbio, consumer technology, crypto and defi and more. The company seeks founders and companies working on novel discoveries and leveraging advances in data science and computing in these influential industries and markets. The new capital will allow TSV to invest in game-changing companies that are transforming the way society and technology interact, transforming traditional industries and helping advance humanity.
“We founded Two Sigma Ventures a decade ago on the belief that as the world becomes more information-rich, most new companies that are transforming the world will do so with a combination of data science and advanced computing,” said Colin Beirne, Partner at Two Sigma Ventures. “Over the past 10 years we have backed over 100 companies that have aligned themselves with this thesis and are proud of the achievements of our founders. This new capital injection marks the beginning of our next chapter as a company and will enable us to fund the next generation of entrepreneurs with world-changing ideas.”
Two Sigma Ventures was founded in 2012 as the venture arm of financial science firm Two Sigma, valued at over $60 billion Modeling, machine learning and more. Two Sigma Ventures invests in founders with a long-term vision and strives to be a lasting partner for every company in its portfolio.
“The team at Two Sigma Ventures has been instrumental in moving us forward, especially during these times of economic uncertainty,” said Job van der Voort, co-founder and CEO of Remote. “Two Sigma Ventures was an early supporter of ours who understood how data can be used for insights and information,” said Will Ahmed, co-founder and CEO of WHOOP. “We have developed novel health monitoring techniques and their expertise in data science and engineering has been tremendously helpful to us over the years.”
“We are fortunate to have the continued support of many eminent institutions that have supported us over the years in our mission to build a world-class venture capital firm,” said Villi Iltchev, Partner at Two Sigma Ventures.
If you are leading an early or growth stage startup and need a strategic venture partner, contact the Two Sigma Ventures team today.
About Two Sigma Ventures
Two Sigma Ventures (TSV) invests in entrepreneurs making a difference with data. Founded in 2012 by Two Sigma, the $60+ billion financial sciences firm, TSV invests in early and growth stage companies across multiple industries including enterprise SaaS, fintech, techbio, consumer tech, crypto and defi and more. Headquartered in New York, TSV has provided capital, strategic advice and industry expertise to innovative companies such as GitLab, Recursion Pharmaceuticals, Remote, WHOOP, Carbon Health, insitro, Socure, Wealthsimple, Timescale and others.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220914005297/en/
Ink House for Two Sigma Ventures